<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Diabetic individuals are considered a vulnerable population during the COVID-19 Pandemic, and several studies noted worse outcomes, including death, among those who get infected. Diabetic emergencies, such as ketoacidosis (DKA), are common and potentially life-threatening conditions in uncontrolled patients. While the pathophysiological background of the relationship between COVID-19 and DKA is not fully understood, early reports available so far indicate that patients with pre-existing diabetes who get infected with the SARS-CoV 2 virus are at higher risk of DKA. It was also suggested that DKA is a poor prognostic sign for infected patients, these being at higher risk of developing worse forms of COVID-19 disease and having high mortality. Therefore, healthcare personnel dealing with such patients face a considerable challenge, as the correct and safe emergency management of such cases is far from established. This article aimed to conduct a study that reviews the current published data available about patients with DKA and COVID-19.</p></abstract>

Diabetic individuals are considered a vulnerable population during the COVID-19 Pandemic, and several studies noted worse outcomes, including death, among those who get infected. Diabetic emergencies, such as ketoacidosis (DKA), are common and potentially life-threatening conditions in uncontrolled patients. While the pathophysiological background of the relationship between COVID-19 and DKA is not fully understood, early reports available so far indicate that patients with pre-existing diabetes who get infected with the SARS-CoV 2 virus are at higher risk of DKA. It was also suggested that DKA is a poor prognostic sign for infected patients, these being at higher risk of developing worse forms of COVID-19 disease and having high mortality. Therefore, healthcare personnel dealing with such patients face a considerable challenge, as the correct and safe emergency management of such cases is far from established. This article aimed to conduct a study that reviews the current published data available about patients with DKA and COVID-19.

The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review

The Journal of Critical Care Medicine

This work is licensed under the Creative Commons Attribution 4.0 International License.

Diabetic individuals are considered a vulnerable population during the COVID-19 Pandemic, and several studies noted worse outcomes, including death, among...

The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review

Article Category: Review

Pubblicato online: 13 nov 2021

Pagine: 6 - 13

Ricevuto: 08 nov 2020

Accettato: 29 giu 2021

DOI: https://doi.org/10.2478/jccm-2021-0024

Parole chiave
COVID-19, diabetes, ketoacidosis, pandemic, pathogenesis

© 2022 Mariana Cornelia Tilinca, Maximilian Cosma Gliga, Andreea Varga, published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review

Article Category: Review

Pubblicato online: 13 nov 2021

Pagine: 6 - 13

Ricevuto: 08 nov 2020

Accettato: 29 giu 2021

DOI: https://doi.org/10.2478/jccm-2021-0024

Parole chiaveCOVID-19, diabetes, ketoacidosis, pandemic, pathogenesis

© 2022 Mariana Cornelia Tilinca, Maximilian Cosma Gliga, Andreea Varga, published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Parole chiave
COVID-19, diabetes, ketoacidosis, pandemic, pathogenesis